A study to assess utilisation and safety of Glycopyrronium Bromide 1mg/5ml Oral Solution as licensed for symptomatic treatment of severe sialorrhoea in children and adolescents aged 3 years and older with chronic neurological disorders in the UK First published 20/02/2023 Last updated 05/05/2026 EU PAS number:EUPAS103644 Study Finalised